GW Pharma (GWPH) Reports Q2 Revenue of $4.6M, Tops Consensus by~$2M

GW Pharma (NASDAQ: GWPH) reported Q2 EPS of $. Revenue for the quarter came in at $4.6 million versus the consensus estimate of $2.62 million.

For earnings history and earnings-related data on GW Pharma (GWPH) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c